Design and application of DNA nanostructures for organelle-targeted delivery of anticancer drugs

Expert Opin Drug Deliv. 2022 Jun;19(6):707-723. doi: 10.1080/17425247.2022.2083603. Epub 2022 Jun 5.

Abstract

Introduction: DNA nanostructures targeting organelles are of great significance for the early diagnosis and precise therapy of human cancers. This review is expected to promote the development of DNA nanostructure-based cancer treatment with organelle-level precision in the future.

Areas covered: In this review, we introduce the different principles for targeting organelles, summarize the progresses in the development of organelle-targeting DNA nanostructures, highlight their advantages and applications in disease treatment, and discuss current challenges and future prospects.

Expert opinion: Accurate targeting is a basic problem for effective cancer treatment. However, current DNA nanostructures cannot meet the actual needs. Targeting specific organelles is expected to further improve the therapeutic effect and overcome tumor cell resistance, thereby holding great practical significance for tumor treatment in the clinic. With the deepening of the research on the molecular mechanism of disease development, especially on tumorigenesis and tumor progression, and increasing understanding of the behavior of biological materials in living cells, more versatile DNA nanostructures will be constructed to target subcellular organelles for drug delivery, essentially promoting the early diagnosis of cancers, classification, precise therapy and the estimation of prognosis in the future.

Keywords: DNA nanostructures; organelle-targeting drug delivery; precision cancer therapy; subcellular location.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents*
  • DNA
  • Drug Delivery Systems
  • Humans
  • Nanostructures*
  • Neoplasms* / diagnosis
  • Neoplasms* / drug therapy
  • Organelles

Substances

  • Antineoplastic Agents
  • DNA